SCHEMBL2802134

SCHEMBL2802134

O=C(O)c1cnn2c(NCc3cccc(Cl)c3)c(C(=O)N3CCC(c4ccccc4)CC3)cnc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AVPR1A P37288 1/20 0.42
TP53 P04637 3/20 0.41
MAPT P10636 2/20 0.41
KDM4E B2RXH2 3/20 0.41
HPGD P15428 2/20 0.41
TSHR P16473 2/20 0.41
USP2 O75604 1/20 0.41
LMNA P02545 1/20 0.41
MAPK1 P28482 1/20 0.41
HSD17B10 Q99714 1/20 0.41
ALDH1A1 P00352 3/20 0.40
EGLN1 Q9GZT9 3/20 0.40
ADRB2 P07550 1/20 0.40
CCKBR P32239 1/20 0.40
SPR P35270 1/20 0.39
SIRT5 Q9NXA8 1/20 0.39
THRB P10828 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2802442 0.92 AVPR1A (0.41) AVPR1ATP53MAPTKDM4EHPGD
SCHEMBL2800936 0.91 STAT6 (0.42) ALDH1A1SPRSIRT5THRB
SCHEMBL2801433 0.91 TP53 (0.39) AVPR1ATP53MAPTKDM4EHPGD
SCHEMBL2801054 0.91 CCR1 (0.45) AVPR1ATP53THRBSMN1; SMN2
SCHEMBL2800791 0.90 ALDH1A1 (0.44) TP53ALDH1A1EGLN1
SCHEMBL2801100 0.88 CHRM4 (0.44) TP53MAPTKDM4ETSHRLMNA
SCHEMBL2801662 0.87 TP53 (0.42) TP53MAPTUSP2SPRTHRB
SCHEMBL2801219 0.86 VNN1 (0.48)
SCHEMBL2800838 0.85 CHRM4 (0.43) TP53MAPTKDM4ETSHRALDH1A1
SCHEMBL2798414 0.85 STAT6 (0.43) TP53MAPTKDM4ETSHRUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2206714-B1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO LTD (JP) 2015-01-21 EP disclosed
US-8729264-B2 Agent for prevention and/or treatment of skin diseases KYOWA HAKKO KIRIN CO., LTD. (JP) 2014-05-20 US disclosed
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-10-07 US disclosed
EP-2206714-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES Kyowa Hakko Kirin Co., Ltd. (JP) 2010-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES TYR, CUTA, SERPINB1 AVPR1A 4789/4885TP53 241/4885MAPT 2533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.